To assess intraoperative and postoperative changes in corneal thickness subsequent to riboflavin-UVA (collagen crosslinking [CXL]) treatment.
Methods:
Forty-one eyes of 41 patients (mean age 27.97 ± 6.97 years) were treated with CXL technique. During treatment, isotonic riboflavin was instilled and corneal thickness measurements were obtained at the cornea apex, the thinnest point, and the pupil center at 15 and 30 minutes, then 3 days, 1 week, and 1, 3, 6, and 12 months after surgery using Pentacam HR and an ultrasound pachymeter.
Results:
A decrease in corneal thickness was detected 15 minutes intraoperatively with a value of 108.95 ± 48.6 μm, and 112.35 ± 47.3 μm at 30 minutes (p<0.001). Three days after the operation, no deviation was found from the initial values (p = 0.17). No further changes were detected during the follow-up period.
Conclusions:
Isotonic riboflavin solution used during CXL treatment resulted in a significant decrease in corneal thickness, but its effect had disappeared by postoperative day 3.
SpoerlEHuhleMSeilerTInduction of cross-links in corneal tissue.Exp Eye Res. 1998; 66:97–103.
3.
KohlhaasMSpoerlESchildeTUngerGWittigCPillunatLEBiomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light.J Cataract Refract Surg. 2006; 32:279–83.
4.
WollensakGSpoerlESeilerTStress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking.J Cataract Refract Surg. 2003; 29:1780–5.
5.
SpoerlEMrochenMSlineyDTrokelSSeilerTSafety of UVA-riboflavin cross-linking of the cornea.Cornea. 2007; 26:385–9.
6.
WollensakGSpörlEReberFPillunatLFunkRCorneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro.Ophthalmic Res. 2003; 35:324–8.
7.
CaporossiABaiocchiSMazzottaCTraversiCCaporossiTParasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study.J Cataract Refract Surg. 2006; 32:837–45.
8.
CaporossiAMazzottaCBaiocchiSCaporossiTLong-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study.Am J Ophthalmol. 2010; 149:585–93.
9.
Raiskup-WolfFHoyerASpoerlEPillunatLECollagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results.J Cataract Refract Surg. 2008; 34:796–801.
10.
GrewalDSBrarGSJainRSoodVSinglaMGrewalSPCorneal collagen crosslinking using riboflavin and ultraviolet-A light for keratoconus: one-year analysis using Scheimpflug imaging.J Cataract Refract Surg. 2009; 35:425–32.
BarrJTWilsonBSGordonMOCLEK Study Group.Estimation of the incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study.Cornea. 2006; 25:16–25.
13.
Cordeiro BarbosaMMBarbosaJBJr, HiraiFEHofling-LimaALEffect of cross-linking on corneal thickness in patients with corneal edema.Cornea. 2010; 29:613–7.
14.
VinciguerraPAlbèETrazzaSRefractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking.Ophthalmology. 2009; 116:369–78.
15.
GreensteinSAFryKLHershPSCorneal topography indices after corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results.J Cataract Refract Surg. 2011; 37:1282–90.
16.
BrooksNOGreensteinSFryKHershPSPatient subjective visual function after corneal collagen crosslinking for keratoconus and corneal ectasia.J Cataract Refract Surg. 2012; 38:615–9.
17.
CaporossiAMazzottaCBaiocchiSCaporossiTDenaroRBalestrazziARiboflavin-UVA-induced corneal collagen cross-linking in pediatric patients.Cornea. 2012; 31:227–31.
18.
EsquenaziSHeJLiNBazanHEImmunofluorescence of rabbit corneas after collagen cross-linking treatment with riboflavin and ultraviolet A.Cornea. 2010; 29:412–7.
19.
WollensakGHistological changes in human cornea after crosslinking with riboflavin and ultraviolet A.Acta Ophthalmol. 2010; 88:e17–8.
20.
WollensakGSpoerlEWilschMSeilerTKeratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment.Cornea. 2004; 23:43–9.
21.
MazzottaCTraversiCBaiocchiSSergioPCaporossiTCaporossiAConservative treatment of keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: qualitative investigation.Eur J Ophthalmol. 2006; 16:530–5.
22.
WollensakGCrosslinking treatment of progressive keratoconus: new hope.Curr Opin Ophthalmol. 2006; 17:356–60.
23.
HafeziFLimitation of collagen cross-linking with hypoosmolar riboflavin solution: failure in an extremely thin cornea.Cornea. 2011; 30:917–9.
24.
WollensakGIomdinaEBiomechanical and histological changes after corneal crosslinking with and without epithelial debridement.J Cataract Refract Surg. 2009; 35:540–6.
VinciguerraPCamesascaFIAlbèETrazzaSCorneal collagen cross-linking for ectasia after excimer laser refractive surgery: 1-year results.J Refract Surg. 2010; 26:486–97.
27.
KollerTIseliHPHafeziFVinciguerraPSeilerTScheimpflug imaging of corneas after collagen cross-linking.Cornea. 2009; 28:510–5.
28.
GreensteinSAShahVPFryKLHershPSCorneal thickness changes after corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results.J Cataract Refract Surg. 2011; 37:691–700.
29.
HovakimyanMGuthoffRKnappeSShort-term corneal response to cross-linking in rabbit eyes assessed by in vivo confocal laser scanning microscopy and histology.Cornea. 2011; 30:196–203.
30.
de SanctisUMissolungiAMutaniBRichiardiLGrignoloFMReproducibility and repeatability of central corneal thickness measurement in keratoconus using the rotating Scheimpflug camera and ultrasound pachymetry.Am J Ophthalmol. 2007; 144:712–8.
31.
GrewalDSBrarGSGrewalSPSAssessment of central corneal thickness in normal, keratoconus, and post-laser in situ keratomileusis eyes using Scheimpflug imaging, spectral domain optical coherence tomography, and ultrasound pachymetry.J Cataract Refract Surg. 2010; 36:954–64.
32.
MazzottaCTraversiCBaiocchiSCorneal healing after riboflavin ultraviolet-A collagen cross-linking determined by confocal laser scanning microscopy in vivo: early and late modifications.Am J Ophthalmol. 2008; 146:527–33.
33.
CorbettMCPrydalJIVermaSOliverKMPandeMMarshallJAn in vivo investigation of the structures responsible for corneal haze after photorefractive keratectomy and their effect on visual function.Ophthalmology. 1996; 103:1366–80.
34.
ReinsteinDZArcherTJGobbeMSilvermanRHColemanDJEpithelial thickness in the normal cornea: three-dimensional display with Artemis very high-frequency digital ultrasound.J Refract Surg. 2008; 24:571–81.
35.
KymionisGDKounisGAPortaliouDMIntraoperative pachymetric measurements during corneal collagen cross-linking with riboflavin and ultraviolet A irradiation.Ophthalmology. 2009; 116:2336–9.
36.
HenriquezMAIzquierdoLJr, BernillaCZakrzewskiPAMannisMRiboflavin/Ultraviolet A corneal collagen cross-linking for the treatment of keratoconus: visual outcomes and Scheimpflug analysis.Cornea. 2011; 30:281–6.
37.
HafeziFMrochenMIseliHPSeilerTCollagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas.J Cataract Refract Surg. 2009; 35:621–4.
38.
KayaVUtineCAYilmazÖFIntraoperative corneal thickness measurements during corneal collagen cross-linking with hypoosmolar riboflavin solution in thin corneas.Cornea. 2012; 31:486–90.
